{"slug":"epigenetics","tag":"epigenetics","variants":["epigenetics"],"description":"No description yet","count":3,"kinds":{"person":3},"related":[{"slug":"clinician-scientist","tag":"clinician-scientist","shared":2},{"slug":"breast-cancer","tag":"breast cancer","shared":1},{"slug":"france","tag":"france","shared":1},{"slug":"leadership","tag":"leadership","shared":1},{"slug":"mds","tag":"mds","shared":1},{"slug":"prostate-cancer","tag":"prostate cancer","shared":1}],"records":[{"id":"bradley-cairns","kind":"person","name":"Bradley Cairns","route":"/people/bradley-cairns/","tldr":"Epigenetics researcher who became CEO of Huntsman Cancer Institute at the University of Utah in September 2025."},{"id":"susan-clark","kind":"person","name":"Susan Clark","route":"/people/susan-clark/","tldr":"Pioneer of DNA methylation analysis whose Garvan laboratory studies how epigenetic changes drive prostate and breast cancer."},{"id":"pierre-fenaux","kind":"person","name":"Pierre Fenaux","route":"/people/pierre-fenaux/","tldr":"Led AZA-001, which showed azacitidine extends survival in high-risk MDS and made hypomethylating agents standard."}]}